Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Inhibikase Therapeutics, Inc. - Common Stock
(NQ:
IKT
)
1.700
+0.010 (+0.59%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 10, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Inhibikase Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
Dr. Milton Werner, CEO of Inhibikase Therapeutics, Inc. is Featured in an Interview With SmallCapsDaily
February 05, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Nasdaq Stocks Above $2 to Watch Now! LVTX, INBS, IKT, PCSA, DYAI
January 29, 2024
Via
AB Newswire
Topics
Retirement
Inhibikase Therapeutics Announces Publication Highlighting Results from its Phase 1 Studies with Risvodetinib
January 29, 2024
From
Inhibikase Therapeutics
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
↗
January 26, 2024
Via
Benzinga
Inhibikase Therapeutics: Q3 Earnings Insights
↗
November 14, 2023
Via
Benzinga
Earnings Preview For Inhibikase Therapeutics
↗
November 13, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
January 25, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
January 24, 2024
Via
Benzinga
Inhibikase Therapeutics Announces Planned Retirement of Chief Financial Officer Joseph Frattaroli
January 16, 2024
Joseph Frattaroli to retire at end of 1Q24; Garth Lees-Rolfe, Vice-President of Finance, to be promoted to Chief Financial Officer
From
Inhibikase Therapeutics
Via
GlobeNewswire
Why Dermata Therapeutics Shares Are Trading Higher By Over 57%; Here Are 20 Stocks Moving Premarket
↗
January 05, 2024
Shares of Dermata Therapeutics, Inc. (NASDAQ: DRMA) rose sharply in pre-market trading after the company announced the issuance of a new patent in Japan for its DMT410 program for the treatment of...
Via
Benzinga
Topics
Intellectual Property
Inhibikase Therapeutics Issues Letter to Shareholders and Provides Update on Development Programs
December 19, 2023
From
Inhibikase Therapeutics
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
December 13, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
December 12, 2023
Via
Benzinga
Why bluebird bio Shares Are Trading Higher? Here Are Other Stocks Moving In Monday's Mid-Day Session
↗
December 11, 2023
Shares of bluebird bio, Inc. (NASDAQ: BLUE) rose sharply during Monday’s session after the company presented updated data from its gene therapy program in transfusion-dependent beta-thalassemia at the...
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
↗
December 04, 2023
Via
Benzinga
Inhibikase Therapeutics Granted Pre-NDA Meeting with the FDA for IkT-001Pro
December 04, 2023
From
Inhibikase Therapeutics
Via
GlobeNewswire
Inhibikase Therapeutics Reports Third Quarter Financial Results and Highlights Recent Period Activity
November 14, 2023
Company to host conference call on Wednesday, November 15, 2023 at 8:00 a.m. ET
From
Inhibikase Therapeutics
Via
GlobeNewswire
Correcting & Replacing -- Inhibikase Therapeutics to Report Third Quarter Financial Results on November 14, 2023
November 07, 2023
From
Inhibikase Therapeutics
Via
GlobeNewswire
Inhibikase Therapeutics to Report Second Quarter Financial Results on November 14, 2023
November 07, 2023
From
Inhibikase Therapeutics
Via
GlobeNewswire
Inhibikase Therapeutics Highlights Unblinded Functional Analysis from the 201 Trial of Risvodetinib in Untreated Parkinson’s Disease and Provides Update on Ongoing Enrollment
October 16, 2023
From
Inhibikase Therapeutics
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
October 05, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
October 04, 2023
Via
Benzinga
Why Cal-Maine Foods Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
↗
October 04, 2023
Gainers Gaucho Group Holdings, Inc. (NASDAQ: VINO) jumped 95.2% to $3.7280. Gaucho Group is planning to list two of its retail properties in Argentina, in San Rafael and Cordoba, for sale, priced at $2...
Via
Benzinga
Inhibikase Therapeutics Receives FDA Orphan Drug Designation for Risvodetinib for the Treatment of Multiple System Atrophy
October 04, 2023
From
Inhibikase Therapeutics
Via
GlobeNewswire
Why Fresh Tracks Therapeutics Shares Are Trading Higher By Around 53%; Here Are 20 Stocks Moving Premarket
↗
September 20, 2023
Gainers TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares rose 70.2% to $0.8937 in pre-market trading after falling 10% on Tuesday.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
September 19, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
↗
August 25, 2023
Via
Benzinga
Why Avalo Therapeutics Shares Are Trading Higher By 25%; Here Are 20 Stocks Moving Premarket
↗
August 18, 2023
Gainers
Via
Benzinga
Earnings Scheduled For August 14, 2023
↗
August 14, 2023
Companies Reporting Before The Bell • Safe & Green Holdings (NASDAQ:SGBX) is likely to report quarterly loss at $0.23 per share on revenue of $6.88 million.
Via
Benzinga
Inhibikase Therapeutics: A Novel And Promising Approach To Neurodegeneration And Oncology
↗
May 24, 2023
IKT's heavily discounted valuation provides a compelling risk/reward given the ability to establish both safety and efficacy in Parkinson’s disease let alone any progress in oncology.
Via
Talk Markets
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
